Status:
UNKNOWN
Metformin Usage Index and Vitamin B12 Status in Egyptian Type 2 Diabetic Patients
Lead Sponsor:
Cairo University
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
20-65 years
Brief Summary
Current data estimated that 451 million people, (age 18-99 years) suffered from diabetes world wide in 2017, and are expected to rise to 693 million by 2045. Among them, type 2 diabetes mellitus (T2DM...
Eligibility Criteria
Inclusion
- Men and women aged 20 to 65 years old with controlled and uncontrolled type 2 DM
Exclusion
- T2DM patients who are pregnant/lactating women,
- newly diagnosed with T2DM (\< 3 months),
- who receive vitamin B12 supplementation or proton-pump inhibitors over the last 6 months,
- alcoholics ,
- known cases of malabsorption (gastrointestinal surgery, inflammatory bowel diseases and gluten allergy),
- chronic kidney disease,
- pernicious anemia
Key Trial Info
Start Date :
May 5 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2022
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT04882332
Start Date
May 5 2021
End Date
October 1 2022
Last Update
March 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University
Cairo, Manial, Egypt, 11521